Chemotherapy is generally needed for middle and late stage esophageal cancer, and the patient should actively cooperate with the treatment according to the doctor’s suggestion.
Chemotherapy is generally needed for middle and advanced esophageal cancer, and chemotherapy regimens are divided into palliative chemotherapy, neoadjuvant chemotherapy and postoperative chemotherapy, and the specific choice of chemotherapy should be decided according to the specific conditions of patients.
Palliative chemotherapy is suitable for middle and advanced esophageal cancer patients who have lost the chance of surgery; neoadjuvant chemotherapy is mainly administered before surgery to help patients shrink tumor lesions and fight for the chance of surgery; postoperative chemotherapy can improve the efficacy of surgery and reduce the risk of local recurrence and metastasis of tumor.
Regardless of which type of chemotherapy is used, the overall goal is to alleviate the symptoms and prolong the survival period of patients with intermediate and advanced esophageal cancer. Patients with middle and late stage esophageal cancer should go to the hospital in time and receive standardized treatment under the guidance of doctors to avoid further development of the disease.